Saturday, August 9, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

UCLA oncologist Dr. Dennis Slamon awarded Szent-Györgyi Prize for groundbreaking research discoveries

June 5, 2024
in Cancer
Reading Time: 4 mins read
0
66
SHARES
597
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Dr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has transformed the treatment of breast cancer, has been awarded the 2024 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

Dr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has transformed the treatment of breast cancer, has been awarded the 2024 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

ADVERTISEMENT

The prize has been awarded annually since 2006 to honor an outstanding scientist whose body of work has had a lasting impact on the understanding of cancer, significantly improving or saving the lives of people with the disease.

The foundation recognized Slamon for his seminal contributions to cancer research that helped shape the field of precision medicine in breast cancer and paved the way for the development of other targeted therapies in oncology. 

“I am honored and humbled to receive this prestigious award,” said Slamon, director of clinical and translational research at the UCLA Health Jonsson Comprehensive Cancer Center and chief of hematology/oncology at the David Geffen School of Medicine at UCLA. “This recognition is not just for me, but for the countless researchers, clinicians, and especially the brave women who have participated in our clinical trials. Together, we have changed the landscape of breast cancer treatment and continue to work on developing cancer treatments that can move from the bench to the bedside more rapidly.”

Slamon first identified the HER2 gene, which is overexpressed in about 25-30% of breast cancer cases and is associated with a more aggressive form of the disease. This non-inherited genetic change defined a new subtype of breast cancer. 

This research and subsequent clinical trials led by Slamon resulted in the development of the breast cancer drug Herceptin, the first gene-based drug to be approved by the U.S. Food and Drug Administration to fight cancer. Since its introduction in 1998, Herceptin has become a cornerstone in the treatment of HER2-positive breast cancer, benefiting millions of women worldwide.

“Dr. Slamon created a new paradigm for modern translational cancer research,” said Dr. Michael Teitell, director of the UCLA Health Jonsson Comprehensive Cancer Center. “His discoveries emphasized the importance of targeting the molecular mechanism, not the histology of cancer, which has become the basis for most new cancer treatments. He has inspired physicians and investigators, including myself, to look beyond their existing assumptions to find more effective ways to treat people with cancer.”  

In addition to Herceptin, Slamon and his team also spearhead the development of the initial targeted inhibitor of CDK-4/6, palbociclib (Ibrance), which was approved by the FDA for women with advanced estrogen receptor-positive, HER-2-negative breast cancer, the most common subtype of the disease. Palbociclib targets CDK-4/6, a critical enzyme that is involved in regulating cell division, preventing the cells from dividing. The use of palbociclib and others drugs in its class has doubled the number of women with the disease who live without any recurrence of the cancer – the largest improvement since the introduction of hormone therapy for breast cancer in the early 1970s.

“I can think of none finer to receive the 2024 Szent Györgyi Prize than Dr. Slamon,” said Dr. Isaac Witz Chair of the 2024 Selection Committee and 2023 Szent-Györgyi Prize Winner in the National Foundation for Cancer Research’s announcement. “The scientific and medical advances he has made for women with breast cancer have created a new paradigm for treatment options and resulting survival rates. I have known of Dr. Slamon’s research for some time and have sincerely admired his approaches, how he thinks differently than others in the field, and his tenacity to tackle the clinical trial process head on to produce results for patients.”

“Dr. Slamon epitomizes our vision of a Szent-Györgyi Prize winner. One of my favorite quotes from our co-founder Albert Szent-Györgyi is ‘to see what others have seen but to think differently than anybody else has thought.’ Dr. Slamon has done just this through his research around the amplification of the HER2 gene, which shed even more light on cancer being a genetic disease and paved the way for a completely new set of targeted treatments for breast cancer patients. Over time as his research produced more and more positive results for cancer patients, many of his research and medical peers began to adopt the viewpoint of ‘breast cancer before Dennis and after Dennis.’  We could not be more proud to have Dr. Slamon as our 2024 Szent-Györgyi Prize winner,” said Dr. Sujuan Ba, NFCR’s President and CEO and the Co-Chair of the 2024 Szent-Györgyi Prize Selection Committee.

The Szent-Györgyi Prize for Progress in Cancer Research, named in honor of Albert Szent-Györgyi, Nobel laureate and co-founder of National Foundation for Cancer Research, will be presented to Slamon at The National Press Club in Washington, DC on Oct. 18 during the Szent-Györgyi Prize Dinner and Award Ceremony, the foundation’s signature event of its daylong Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship. The award highlights the foundation’s investment in funding long-term and transformative pioneering research that will produce scientific breakthroughs and promote public awareness of the importance of basic cancer research.



Share26Tweet17
Previous Post

A cracking discovery – eggshell waste can recover rare earth elements needed for green energy

Next Post

Many firearm owners can’t recognize when a cable lock is properly installed

Related Posts

Cancer

Revolutionizing Fetal Congenital Heart Disease: MRI’s Impact

August 9, 2025
blank
Cancer

Enhancing Pediatric Abdominal MRI Quality with Deep Learning

August 9, 2025
blank
Cancer

FAM111B Knockdown Suppresses Ovarian Cancer by Downregulating MYC

August 9, 2025
blank
Cancer

Lung Ultrasound Transforms Neonatal and Pediatric Respiratory Care

August 9, 2025
blank
Cancer

Understanding Tenosynovial Giant Cell Tumors in Kids

August 9, 2025
blank
Cancer

120 mmHg Limit: Key to Safe Intussusception Reduction

August 8, 2025
Next Post

Many firearm owners can’t recognize when a cable lock is properly installed

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27531 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    943 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    507 shares
    Share 203 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Revolutionizing Fetal Congenital Heart Disease: MRI’s Impact
  • Distinct Coral Reef Regions Identified in Red Sea
  • Scientists Discover Novel Mechanism Behind Cellular Tolerance to Anticancer Drugs
  • Enhancing Pediatric Abdominal MRI Quality with Deep Learning

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,860 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading